H Sung J Ferlay RL Siegel M Laversanne I Soerjomataram A Jemal F Bray 2021 Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for CA 71 3 209 249

PubMed  Google Scholar 

Erratum (2020) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA, 70(4):313

R Kloeckner PR Galle J Bruix 2021 Local and regional therapies for hepatocellular carcinoma Hepatology 73 137 149

Article  PubMed  Google Scholar 

A Vogel A Cervantes I Chau B Daniele JM Llovet T Meyer JC Nault 2018 Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 29 4 238 255

Article  Google Scholar 

European Association for the Study of the Liver 2012 European Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 4 908 943

Article  Google Scholar 

JA Marrero LM Kulik CB Sirlin AX Zhu RS Finn MM Abecassis 2018 Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases Hepatology 68 2 723 750

Article  PubMed  Google Scholar 

M Omata AL Cheng N Kokudo M Kudo JM Lee J Jia 2017 Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Hepatol Int 11 4 317 370

Article  PubMed  Google Scholar 

L Liang C Li YK Diao HD Jia H Xing TM Pawlik WY Lau 2020 Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis Ther Adv Gastroenterol 13 1756284820977693

Article  Google Scholar 

H Wang PC Du MC Wu WM Cong 2018 Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion Hepatobiliary Surg Nutrit 7 6 418 428

Article  Google Scholar 

K Wang YJ Xiang HM Yu YQ Cheng YY Qin WJ Wang XP Zhang 2022 A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion Eur J Surg Oncol 48 6 1348 1355

Article  PubMed  Google Scholar 

F Liu X Guo W Dong W Zhang S Wei S Zhang X Zhu 2020 Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection Int J Biol Sci 16 16 3210 3220

Article  CAS  PubMed  PubMed Central  Google Scholar 

YF Zhang H Shang XL Zeng H Ji YM Li HW Lu 2018 Postoperative adjuvant chemo (embolization) therapy for hepatocellular carcinoma with portal vein tumor thrombosis Onco Targets Ther 11 5407 5417

Article  CAS  PubMed  PubMed Central  Google Scholar 

YP Qi JH Zhong ZY Liang J Zhang B Chen CZ Chen LQ Li 2019 Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion Am J Surg 217 4 739 744

Article  PubMed  Google Scholar 

L Wang Q Ke N Lin Y Zeng J Liu 2019 Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis Scand J Gastroenterol 54 5 528 537

Article  CAS  PubMed  Google Scholar 

A Sugioka Y Kato Y Tanahashi 2017 Systematic extrahepatic Glissonean pedicle isolation for anatomical liver resection based on Laennec's capsule: proposal of a novel comprehensive surgical anatomy of the liver J Hepatobiliary Pancreat Sci 24 1 17 23

Article  PubMed  PubMed Central  Google Scholar 

CE Costentin CR Ferrone RS Arellano S Ganguli TS Hong AX Zhu 2017 Hepatocellular carcinoma with macrovascular invasion: defining the optimal treatment strategy Liver cancer 6 4 360 374

Article  CAS  PubMed  PubMed Central  Google Scholar 

YY Wang LJ Wang D Xu M Liu HW Wang K Wang X Zhu 2019 Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion HPB (Oxford) 21 4 425 433

Article  PubMed  Google Scholar 

Y Li Y Zhang Q Fang X Zhang P Hou H Wu X Wang 2021 Radiomics analysis of [F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma Eur J Nucl Med Mol Imaging 48 8 2599 2614

Article  CAS  PubMed  Google Scholar 

European Association for Study of Liver 2012 European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma Eur J Cancer 48 5 599 641

Article  Google Scholar 

National Cancer Institute: common terminology criteria for adverse events, version 5.0. 2020: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.

MS Schröder AC Culhane J Quackenbush B Haibe-Kains 2011 survcomp: an R/Bioconductor package for performance assessment and comparison of survival models Bioinformatics 27 22 3206 3208

Article  PubMed  PubMed Central  Google Scholar 

PJ Heagerty T Lumley MS Pepe 2000 Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 56 2 337 344

Article  CAS  PubMed  Google Scholar 

ME Cohen CY Ko KY Bilimoria L Zhou K Huffman X Wang Y Liu 2013 Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus J Am College Surg. 217 2 336 346

Article  Google Scholar 

AJ Vickers EB Elkin 2006 Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 6 565 574

Article  PubMed  PubMed Central  Google Scholar 

RL Camp M Dolled-Filhart DL Rimm 2004 X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 21 7252 7259

Article  CAS  PubMed  Google Scholar 

A Vogel A Cervantes I Chau B Daniele JM Llovet T Meyer JC Nault 2018 Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol. 29 iv238 iv255

Article  CAS  PubMed  Google Scholar 

X Chen B Zhang X Yin Z Ren S Qiu J Zhou 2013 Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection J Cancer Res Clin Oncol 139 5 773 781

Article  CAS  PubMed  Google Scholar 

Y-C Cheng T-W Chen H-L Fan C-Y Yu H-C Chang C-B Hsieh 2014 Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantation Ann Transplant 19 309 316

Article  CAS  PubMed  Google Scholar 

P Bhargava DC Gammon D Kim D Phillips S Mehta L Shick L Cicalese 2004 Chemoembolization (CE) with carboplatin and doxorubicin for hepatocellular cancer (HCC): introduction of a novel combination and preliminary results J Clin Oncol. 22 14_suppl 4275 4275

Article  Google Scholar 

W Wei PE Jian SH Li ZX Guo YF Zhang YH Ling 2018 Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety Cancer Commun (Lond) 38 1 61

PubMed  Google Scholar 

Z Wang Z Ren Y Chen J Hu G Yang L Yu X Yang 2018 Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled studyadjuvant TACE for HCC after resection Clin Cancer Res 24 9 2074 2081

Article  CAS  PubMed  Google Scholar 

J-L Raoul A Forner L Bolondi TT Cheung R Kloeckner T Baere de 2019 Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence Cancer Treat Rev 72 28 36

Article  CAS  PubMed  Google Scholar